Page last updated: 2024-08-24

2-methoxyestradiol and Cancer of Pituitary

2-methoxyestradiol has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Du, G; Huang, L; Xiao, Z; Zhao, Y1

Other Studies

1 other study(ies) available for 2-methoxyestradiol and Cancer of Pituitary

ArticleYear
HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression.
    Oncology reports, 2013, Volume: 30, Issue:5

    Topics: 2-Methoxyestradiol; Adult; Animals; Antineoplastic Agents, Alkylating; Cell Survival; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Pituitary Neoplasms; Temozolomide; Tumor Suppressor Proteins

2013